Physician profile
Stuart Reynolds
NPI 1316215171
$1,364.24
in general payments reported to CMS, 2019-2025
10 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2021: $400 · 2022: $20.26 · 2023: $199 · 2024: $247 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.28 |
| Education | $167.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuwellis, INC. | $473.11 | 2019-2025 | Aquadex Smartflow Console |
| C. R. Bard, INC. & Subsidiaries | $400.00 | 2021 | |
| Edwards Lifesciences Corporation | $210.69 | 2019-2023 | Hemosphere |
| Baxter Healthcare | $72.71 | 2019 | |
| Shionogi INC | $64.79 | 2025 | Fetroja |
| Merck Sharp & Dohme LLC | $42.03 | 2019-2023 | Recarbrio, Zerbaxa, Dificid |
| Abbvie INC. | $38.38 | 2023-2024 | |
| Inari Medical, INC. | $26.05 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Recor Medical INC | $24.91 | 2024 | Paradise Renal Denervation System |
| Pfizer INC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.